Changes in externalizing and internalizing symptoms among African American female adolescents over 1 year following a mother–daughter sexual health intervention
| Autor: | Sally Freels, Bethany C. Bray, Ashley D. Kendall, Christina B. Young, Geri R Donenberg, Erin Emerson |
|---|---|
| Rok vydání: | 2020 |
| Předmět: |
050103 clinical psychology
Adolescent Sexual Behavior Sexually Transmitted Diseases Mothers Health Promotion PsycINFO Anxiety Article Acquired immunodeficiency syndrome (AIDS) Intervention (counseling) medicine Humans 0501 psychology and cognitive sciences Reproductive health Depression business.industry 05 social sciences Multilevel model medicine.disease Mental health Black or African American Aggression Psychiatry and Mental health Clinical Psychology Mental Health Health promotion Female Sexual Health business Psychology Human Females Clinical psychology |
| Zdroj: | J Consult Clin Psychol |
| ISSN: | 1939-2117 0022-006X |
| Popis: | Objective African American female adolescents face disparities compared with White peers in the interrelated areas of mental health symptoms and sexually transmitted infection (STI) acquisition. IMARA (Informed, Motivated, Aware and Responsible about AIDS) is a group-based mother-daughter intervention addressing these factors among African American teenagers. Previous work demonstrated that female adolescents who received IMARA were 43% less likely than controls to evidence a new STI at 1 year. This report aimed to provide the 1st test of IMARA on externalizing and internalizing symptoms and an exploratory analysis of whether symptom improvements were associated with the protective effect of treatment against future STIs. Method Female African Americans aged 14-18 years (M = 16; N = 199) were randomly assigned to IMARA or a health promotion control group matched for time and structure. They completed the Youth Self-Report of externalizing and internalizing symptoms at baseline and at 6 and 12 months and were tested for STIs at baseline and 12 months; positive cases were treated. Hierarchical linear modeling tested symptom change over time, including the moderating effects of baseline symptoms. Results Among participants who entered with high versus lower externalizing symptoms, those who received IMARA showed a slightly greater decrease in externalizing scores relative to the control (p = .035). For these youth, symptom improvements appeared to be associated with IMARA's protective effect against new STIs. Treatment was not associated with internalizing symptom change (p > .05). Conclusion IMARA shows promise in modestly reducing self-reported externalizing symptoms, although only for participants with high scores at baseline. The possibility that externalizing symptom improvement is linked with reduced STI acquisition warrants future examination. (PsycInfo Database Record (c) 2020 APA, all rights reserved). |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|